Valued Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95K Hold
10
﹤0.01% 672
2026
Q1
$2.25K Hold
10
﹤0.01% 548
2025
Q4
$2.41K Hold
10
﹤0.01% 387
2025
Q3
$2.74K Hold
10
﹤0.01% 357
2025
Q2
$2.58K Hold
10
﹤0.01% 358
2025
Q1
$2.24K Hold
10
﹤0.01% 402
2024
Q4
$2.29K Hold
10
﹤0.01% 393
2024
Q3
$2.44K Hold
10
﹤0.01% 350
2024
Q2
$1.92K Hold
10
﹤0.01% 369
2024
Q1
$1.98K Hold
10
﹤0.01% 358
2023
Q4
$1.48K Buy
+10
New +$1.54K ﹤0.01% 337

Other funds holding RMD

Valued Wealth Advisors's RMD Position: Q2 2026 in Review

Valued Wealth Advisors held its ResMed (RMD) position steady in Q2 2026 at 10 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Valued Wealth Advisors first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.74K in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Valued Wealth Advisors held 10 shares of ResMed worth $1.95K as of Q2 2026.
  • Valued Wealth Advisors left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #672 holding.
  • Valued Wealth Advisors first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • Valued Wealth Advisors's ResMed position peaked at $2.74K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.